psychemedics.com - PMD Business Value to Revenue

Public company logo of psychemedics.com (PMD)

The resilience of the Psychemedics (PMD) business model is based on the expansion of B2B hair analysis services for the corporate sector. The company's EV-to-revenue multiple confirms this trend, and the metric currently stands at . Market dominance is driven by high-precision tests for police and employers, while operational efficiency is maintained through the regular upgrading of mass spectrometers in the laboratories.

Psychemedics (PMD): Enterprise Value-to-Revenue Ratio from 07/04/2022 to 11/19/2026

Psychemedics - analytical breakdowns and key metrics (PMD)

- market value and analyst target forecast:
Fundamental company valuation:PMD (Psychemedics)
Core merchandise of Psychemedics Inc

The EV/Sales metric determines the total value of the business, including debt, relative to the volume of generated revenue, allowing for an assessment of the capitalization efficiency of operational turnover. By analyzing the EV/Sales history, an investor can identify asset overvaluation, which is particularly critical for Psychemedics (PMD) due to its narrow specialization in corporate hair testing and dependence on US hiring cycles.

Competitor analysis for Psychemedics

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio HeartSciences (HSCS)|Company Value to Revenue Biomerica Inc. BMRA|EV/Sales Multiple CDIO (Cardio Diagnostics)|ONCO - Company Value to Revenue|VRAX: Company Value to Revenue|bluejaydx.com (BJDX) - Company Value to Revenue|AWH: EV/Sales Multiple|AXDX: Enterprise Value-to-Revenue Coefficient|CNTG (CENTOGENE N.V.) - EV/Sales Multiple|Company Value to Revenue Enzo Biochem, Inc. (ENZ)|FRES - Enterprise Value to Sales Volume|Genetic Technologies Limited (GENE) - Enterprise Value-to-Sales Ratio|EV/Sales Multiple ME (23andme.com)